25.81 USD
↘ 0.40 (1.52%)LIVE (AS OF 01:21 PM EDT)
Zymeworks Inc.
ZYMENASDAQ • USD
Market: OPEN
ZYME is currently priced at $25.81. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$26.42
High?$26.79
Low?$25.70
Prev. Close?$26.21
Volume?233.4K
Avg. Volume?852.2K
VWAP?$26.18
Rel. Volume?0.27x
Bid / Ask
Bid?$22.93 × 200
Ask?$25.95 × 200
Spread?$3.02
Midpoint?$24.44
Valuation & Ratios
Market Cap?1.9B
Shares Out?71.0M
Float?42.8M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?23.40
EPS?-$2.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Themes
Employees
264
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2017-04-28
Address
108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709
Phone: 302-274-8744
MIDDLETOWN, DE 19709
Phone: 302-274-8744
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?1
Momentum?3
Short Sent.?54
Piotroski F-Score?1/9Weak
Altman Z-Score?-1.01Distress
Confidence?61%Moderate
Short InterestHigh
Short % of Float?11.54%High
Short Interest?4.9M
Days to Cover?8.0
Free Float42.8M
Avg Daily Volume619.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?6.32Strong
Quick Ratio?6.32Strong
Cash Ratio?3.80Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?23.40HIGH▾
Peers100
S&P3
P/S?50.65HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-11.3CHEAP▾
S&P97
EV/Sales?45.82HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-186.6%WEAK▾
S&P3
ROA?-37.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-120544000
Enterprise Value?$1.7B
Fundamentals ratios updated end of day